Patents by Inventor Vasundhara Shukla

Vasundhara Shukla has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • POLYMERIC NANOPARTICLES PROVIDING NUCLEIC ACIDS ENCODING TNF-a
    Publication number: 20230157969
    Abstract: The present invention relates to polymeric nanoparticles comprising a cytokine or a nucleic acid encoding for a cytokine, pharma-ceutical compositions comprising the same, and methods for treating certain diseases comprising administering these polymeric nanoparticles to a subject in need thereof.
    Type: Application
    Filed: October 6, 2022
    Publication date: May 25, 2023
    Inventors: Surender KHARBANDA, Vasundhara Shukla, Donald Kufe, Harpal Singh
  • Polymeric nanoparticles providing nucleic acids encoding TNF-?
    Patent number: 11484507
    Abstract: The present invention relates to polymeric nanoparticles comprising a cytokine or a nucleic acid encoding for a cytokine, pharmaceutical compositions comprising the same, and methods for treating certain diseases comprising administering these polymeric nanoparticles to a subject in need thereof.
    Type: Grant
    Filed: November 1, 2017
    Date of Patent: November 1, 2022
    Assignee: Hillstream BioPharma, Inc.
    Inventors: Surender Kharbanda, Vasundhara Shukla, Donald Kufe, Harpal Singh
  • POLYMERIC NANOPARTICLES
    Publication number: 20190321305
    Abstract: The present invention relates to polymeric nanoparticles comprising a cytokine or a nucleic acid encoding for a cytokine, pharmaceutical compositions comprising the same, and methods for treating certain diseases comprising administering these polymeric nanoparticles to a subject in need thereof.
    Type: Application
    Filed: November 1, 2017
    Publication date: October 24, 2019
    Inventors: SURENDER KHARBANDA, VASUNDHARA SHUKLA, DONALD KUFE, HARPAL SINGH
  • Nanocomplex containing cationic peptide for biomolecule delivery
    Patent number: 9572893
    Abstract: The present invention relates to developing an optimally efficient arginine-histidine-cysteine based peptide comprising nanocomplex that can deliver biomolecules across varied cell lines without any oxidative procedure through formation of monodisperse nanoparticles with sizes ranging between 50 and 110 nm.
    Type: Grant
    Filed: November 6, 2013
    Date of Patent: February 21, 2017
    Assignee: Council of Scientific and Industrial Research
    Inventors: Munia Ganguli, Anita Mann, Vasundhara Shukla, Manika Vij
  • NANOCOMPLEX CONTAINING CATIONIC PEPTIDE FOR BIOMOLECULE DELIVERY
    Publication number: 20150343086
    Abstract: The present invention relates to developing an optimally efficient arginine-histidine-cysteine based peptide comprising nanocomplex that can deliver biomolecules across varied cell lines without any oxidative procedure through formation of monodisperse nanoparticles with sizes ranging between 50 and 110 nm.
    Type: Application
    Filed: November 6, 2013
    Publication date: December 3, 2015
    Inventors: Munia Ganguli, Anita Mann, Vasundhara Shukla, Manika Vij